DE69739306D1 - Verwendung von Taurin, Homotaurin und/oder Methionin zur Erzeugung von Narkose. - Google Patents

Verwendung von Taurin, Homotaurin und/oder Methionin zur Erzeugung von Narkose.

Info

Publication number
DE69739306D1
DE69739306D1 DE69739306T DE69739306T DE69739306D1 DE 69739306 D1 DE69739306 D1 DE 69739306D1 DE 69739306 T DE69739306 T DE 69739306T DE 69739306 T DE69739306 T DE 69739306T DE 69739306 D1 DE69739306 D1 DE 69739306D1
Authority
DE
Germany
Prior art keywords
homotaurine
narcosis
taurine
methionine
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69739306T
Other languages
English (en)
Inventor
Tadaomi Miyamoto
Koho Miyamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meddiss Inc
Original Assignee
Meddiss Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meddiss Inc filed Critical Meddiss Inc
Application granted granted Critical
Publication of DE69739306D1 publication Critical patent/DE69739306D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69739306T 1996-03-26 1997-03-21 Verwendung von Taurin, Homotaurin und/oder Methionin zur Erzeugung von Narkose. Expired - Lifetime DE69739306D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62260696A 1996-03-26 1996-03-26

Publications (1)

Publication Number Publication Date
DE69739306D1 true DE69739306D1 (de) 2009-04-23

Family

ID=24494811

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69739306T Expired - Lifetime DE69739306D1 (de) 1996-03-26 1997-03-21 Verwendung von Taurin, Homotaurin und/oder Methionin zur Erzeugung von Narkose.
DE69733329T Expired - Lifetime DE69733329T2 (de) 1996-03-26 1997-03-21 Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69733329T Expired - Lifetime DE69733329T2 (de) 1996-03-26 1997-03-21 Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen

Country Status (6)

Country Link
US (2) US6015835A (de)
EP (2) EP0797992B1 (de)
JP (1) JPH1045578A (de)
AU (1) AU703540B2 (de)
CA (1) CA2200795C (de)
DE (2) DE69739306D1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
FR2772271B1 (fr) * 1997-12-11 2000-09-01 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
EP1023843B1 (de) * 1999-01-29 2005-06-22 Sportmedizin Team Vertriebs GmbH Zusammensetzung zur Leistungsförderung bei sportlicher Tätigkeit, ihre Herstellung und Verwendung als diätetisches Lebensmittel
IL146143A0 (en) * 1999-04-28 2002-07-25 Univ Kingston Compositions and methods for treating amyloidosis
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
CA2320556A1 (en) 1999-09-29 2001-03-29 Queen's University At Kingston N,n-dichlorinated omega amino acids and uses thereof
DE60131644T2 (de) * 2000-05-09 2008-10-30 Nitromed, Inc., Lexington Infrarotthermographie und behandlung von sexuellen dysfunktionen
EP1256360A1 (de) * 2001-05-10 2002-11-13 Université de Liège Hypertonisches Medikament insbesondere zur Verwendung in der Flüssigkeitstherapie
JP5084089B2 (ja) * 2001-06-14 2012-11-28 大塚製薬株式会社 医薬組成物
JP5028639B2 (ja) * 2001-08-02 2012-09-19 成男 太田 ミトコンドリア病の予防又は治療薬
FR2833840B1 (fr) * 2001-12-21 2010-06-18 Rytek Methodes et compositions pour le traitement de pathologies respiratoires
FR2833839A1 (fr) * 2001-12-21 2003-06-27 Rytek Methodes et compositions pour le traitement de pathologies respiratoires
US7452877B2 (en) 2002-03-15 2008-11-18 Rytek Methods for treating digestive functional pathologies
FR2837103B1 (fr) * 2002-03-15 2004-07-09 Rytek Compositions pour le traitement de pathologies fonctionelles digestives
FR2844201A1 (fr) * 2002-09-06 2004-03-12 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
US20050142191A1 (en) 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005120489A2 (en) * 2004-06-04 2005-12-22 Molecular Therapeutics, Inc. Treatment of central nervous system disorders or injuries with d-methionine
MX2007005507A (es) * 2004-11-12 2008-03-13 Neurochem Int Ltd Metodos y composiciones fluoradas para el tratamiento de padecimientos relacionados con amiloides.
AU2005310979A1 (en) * 2004-11-16 2006-06-08 Bellus Health (International) Limited Compounds for the treatment of CNS and amyloid associated diseases
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
CA2900876A1 (en) 2004-12-22 2006-08-17 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
TW200716088A (en) 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
ATE481094T1 (de) 2005-12-22 2010-10-15 Kiacta Sarl Behandlung von diabetischer nephropathie
KR101443573B1 (ko) 2006-10-12 2014-11-03 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
AU2007337806A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
CA2702604C (en) 2008-09-22 2013-12-03 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
US20110313040A1 (en) * 2008-11-14 2011-12-22 Bellus Health Inc. Organic nutrient salts, methods of preparation and uses
FR2953411B1 (fr) * 2009-12-03 2012-02-03 Biocodex Combinaison synergique de composes analgesiques
US10918612B2 (en) * 2013-01-22 2021-02-16 Markus Zwickl Combinations with 2-aminoethanesulfonic acid
ITUA20161679A1 (it) * 2016-03-15 2017-09-15 Neuraxpharm Italy S P A Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457281A1 (fr) * 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
US5084007A (en) * 1989-08-11 1992-01-28 Malin David H Method for chemical promotion of the effects of low current transcranial electrostimulation
WO1991011117A2 (en) * 1990-02-05 1991-08-08 Board Of Regents, The University Of Texas System Dietary supplements comprising vitamins and minerals
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds

Also Published As

Publication number Publication date
DE69733329D1 (de) 2005-06-30
EP0797992B1 (de) 2005-05-25
DE69733329T2 (de) 2006-02-02
CA2200795C (en) 2000-11-28
JPH1045578A (ja) 1998-02-17
AU703540B2 (en) 1999-03-25
US6316501B1 (en) 2001-11-13
EP0797992A2 (de) 1997-10-01
US6015835A (en) 2000-01-18
EP1473032A1 (de) 2004-11-03
CA2200795A1 (en) 1997-09-26
EP1473032B1 (de) 2009-03-11
EP0797992A3 (de) 1998-06-03
AU1639297A (en) 1997-10-09

Similar Documents

Publication Publication Date Title
DE69739306D1 (de) Verwendung von Taurin, Homotaurin und/oder Methionin zur Erzeugung von Narkose.
DE59902314D1 (de) Oligomerisiertes Organopolysiloxan-Cokondensat, dessen Herstellung und dessen Verwendung zur Behandlung von Oberflächen
ATE81978T1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DE69913610D1 (de) Herstellung von Durchkontaktierungen für mehrlagige, induktive oder andere Bauteile
DE69718285D1 (de) Antiperspirans oder deodorans mit siliconlatex
ATA189691A (de) Hpth-peptide, ihre herstellung und verwendung
DE3773965D1 (de) Sehnen-prothese.
DE69603734D1 (de) Blockcopolymere von Polyolefinen mit Polyurethanen, Copolyestern oder Copolyamiden und ihre Verwendung
DE69704929D1 (de) Prionen-freies kollagen und von kollagen abgeleitete produkte und implantate für verschiedene biomedizinische anwendungen und methoden für ihre herstellung.
DE69926604D1 (de) Strahlungsundurchlässiges kollagenbiomaterial für implantierbare vorrichtungen
DE69434028D1 (de) Regelung bei einer Behandlung mit kontinuierlichem positiven Atemwegsdruck
DE69727332D1 (de) Zubereitungen enthaltend Kollagen, Vitamin D3 und Kalzium zur Verstärkung des Knochens
DE59705007D1 (de) Elektrolyseapparat zur herstellung von halogengasen
DE69804224D1 (de) Herstellung von sulfiden und seleniden
DE69107011D1 (de) Prothetisches oder orthopädisches Gelenk.
DE69709526D1 (de) Verfahren zur Herstellung von Methionin
DE69607827D1 (de) Herbizide zusammensetzungen von 4-benzoylisoxazolen oder 2-cyano-1,3-dionherbiziden und antidots für diese
DE69517252D1 (de) Perfluoroalkylsulfid-,-sulfon-, -polysulfon- und -polysulfiddiole
DE59509950D1 (de) Vorrichtung zur herstellung von längs- und/oder quergereckten, insbesondere simultan biaxial gereckten folienbahnen
AR016981A2 (es) Polipeptidos sinteticos
DE69118428D1 (de) Prozess zur Herstellung von Polyarylensulfiden
ATA102389A (de) Saeureadditionssalze aus amidiertem taurin oder glycin, deren herstellung und verwendung
ATE30730T1 (de) Elastomere copolymere, ihre herstellung und ihre verwendung.
DE69727674D1 (de) Zur herstellung von gebrannten mustern
DE69512674D1 (de) Konversion von nylon und/oder nylon 6,6 zur adipinsäure

Legal Events

Date Code Title Description
8364 No opposition during term of opposition